Ishida Teruyoshi, Shimokawa Hidehiko, Kawaguchi Kouji, Nose Naohiro, Ikegami Tohru, Itoh Hiroyuki, Kido Akinori, Sasaki Yukiharu, Ezaki Takahiro
Dept. of Surgery, Hiroshima Red Cross Hospital, Atomic Bomb Survivors Hospital.
Gan To Kagaku Ryoho. 2002 Sep;29(9):1643-6.
We report a case in which weekly paclitaxel (TXL) administration was effective for gastric cancer with malignant ascites. TXL (80 mg/m2) was infused over 1 hour after short premedication on an outpatient basis. Administration was continued for 3 weeks followed by 1 week rest. The patient was a 49-year-old woman who suffered from non-resectable gastric cancer, staged intraoperatively as having severe lymph node metastasis and malignant ascites. As an outpatient treatment, she was first treated with 5-fluorouracil combined with high-dose Leucovorin for 4 cycles. However, she complained of abdominal fullness and ascites, and received weekly TXL administration as the second line treatment. The ascites had completely disappeared 3 months after administration. The toxic events were anemia (grade 1) and alopecia (grade 2). No major adverse effects such as hypersensitivity reaction, leukopenia or peripheral neuropathy were observed.
我们报告了一例每周使用紫杉醇(TXL)治疗伴有恶性腹水的胃癌有效的病例。门诊患者在短时间预处理后,将TXL(80mg/m²)在1小时内静脉输注。给药持续3周,随后休息1周。该患者为一名49岁女性,患有不可切除的胃癌,术中分期为严重淋巴结转移和恶性腹水。作为门诊治疗,她首先接受了5-氟尿嘧啶联合高剂量亚叶酸钙治疗4个周期。然而,她主诉腹胀和腹水,并接受每周一次的TXL给药作为二线治疗。给药3个月后腹水完全消失。毒性事件为贫血(1级)和脱发(2级)。未观察到诸如过敏反应、白细胞减少或周围神经病变等严重不良反应。